Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy

Clinical uncertainty exists regarding which assay should be designated as the standard monitoring coagulation test for intravenous unfractionated heparin (UFH). Several studies have compared the use of activated partial thromboplastin time (aPTT) and antifactor-Xa (anti-Xa) and have come out with va...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaughlin, Kevin, Rimsans, Jessica, Sylvester, Katelyn W., Fanikos, John, Dorfman, David M., Senna, Patricia, Connors, Jean M., Goldhaber, Samuel Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829967/
https://www.ncbi.nlm.nih.gov/pubmed/31530176
http://dx.doi.org/10.1177/1076029619876030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829967/
https://www.ncbi.nlm.nih.gov/pubmed/31530176
http://dx.doi.org/10.1177/1076029619876030

Ejemplares similares